IPO registrations (S-1, F-1) · Registrants
ADOLOR CORP
- SEC CIK
- 1076167 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2000-02-08, last 2001-07-20; 2 initial registrations, 11 amendments
- Outcome
- Final prospectus filed 2000-11-14
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Business address
- 700 PENNSYLVANIA DRIVE, Exton, PA 19341
- EIN
- 31-1429198
- EDGAR entity type
- operating
- Insiders and CEO pay
- ADOLOR CORP on the corporate pages
Offering terms
- Proposed price range
- $15.00–$17.00 per share (S-1/A filed 2000-11-09)
- Final price
- $15.00 per share, within the range (424B1 filed 2000-11-14, an initial public offering)
- Shares sold
- 6,000,000
- Gross proceeds
- $90,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol ADLR
- Lead underwriters
- Merrill Lynch; Lehman Brothers (1,995,000 shares); Pacific Growth Equities, Inc (1,140,000 shares)
- Syndicate
- BofA Securities (60,000); J.P. Morgan (60,000); Lazard (60,000); Prudential Securities (60,000); Utendahl Capital Partners, L.P (60,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: Adolor Corporation Fuzzy (name and state)
- Form 5500 plan sponsor: ADOLOR CORPORATION EXACT (EIN (EXACT))
- Federal award recipient: ADOLOR CORPORATION Fuzzy (name and state)
- SEC filer: ADOLOR CORP EXACT (CIK (EXACT))
- Person page: Donald E Nickelson Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Thomas P Hess Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer))
Filings 17
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2000-02-08 | S-1 | S-1 (registration) | ADOLOR CORP | 0000950109-00-000310 ↗ |
| 2000-02-18 | S-1/A | S-1/A (amendment) | ADOLOR CORP | 0001036050-00-000217 ↗ |
| 2000-03-13 | S-1/A | S-1/A (amendment) | ADOLOR CORP | 0000950109-00-000934 ↗ |
| 2000-03-21 | S-1/A | S-1/A (amendment) | ADOLOR CORP | 0001036050-00-000389 ↗ |
| 2000-04-03 | S-1/A | S-1/A (amendment) | ADOLOR CORP | 0001036050-00-000546 ↗ |
| 2000-04-07 | S-1/A | S-1/A (amendment) | ADOLOR CORP | 0001036050-00-000571 ↗ |
| 2000-09-29 | S-1/A | S-1/A (amendment) | ADOLOR CORP | 0001036050-00-001806 ↗ |
| 2000-10-10 | S-1/A | S-1/A (amendment) | ADOLOR CORP | 0001036050-00-001826 ↗ |
| 2000-10-23 | S-1/A | S-1/A (amendment) | ADOLOR CORP | 0001036050-00-001865 ↗ |
| 2000-11-08 | S-1/A | S-1/A (amendment) | ADOLOR CORP | 0000950109-00-004378 ↗ |
| 2000-11-09 | S-1/A | S-1/A (amendment) | ADOLOR CORP | 0001036050-00-001945 ↗ |
| 2000-11-14 | 424B1 | 424B1 (final prospectus) | ADOLOR CORP | 0001036050-00-002018 ↗ |
| 2000-11-15 | 424B1 | 424B1 (final prospectus) | ADOLOR CORP | 0001036050-00-002052 ↗ |
| 2001-06-29 | S-1 | S-1 (registration) | ADOLOR CORP | 0000950109-01-501981 ↗ |
| 2001-07-20 | S-1/A | S-1/A (amendment) | ADOLOR CORP | 0001021408-01-503677 ↗ |
| 2001-07-23 | 424B1 | 424B1 (final prospectus) | ADOLOR CORP | 0000950109-01-502308 ↗ |
| 2001-12-07 | 424B1 | 424B1 (final prospectus) | ADOLOR CORP | 0000950109-01-505525 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2000-11-09 | S-1/A | registration statement | $15.00–$17.00 | 6,000,000 | - | Nasdaq ADLR | 4 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, underwriting table 1, cover names 3 | document ↗ | |
| 2000-11-14 | 424B1 | final prospectus | $15.00 | 6,000,000 | $90,000,000 | Nasdaq ADLR | 8 | primary document; price sentence, shares headline, proceeds table, underwriting table 7, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BARRETT JAMES E | Officer | Sr VP,CSO & President,Research; SVP, CSO & President Research | 2 | 2006–2007 | |
| DOUGHERTY MICHAEL R | Director,Officer; Officer | President & CEO; SVP & Chief Operating Officer | 16 | 2006–2011 | |
| Graham Roger D JR | Officer | SVP Sales & Marketing | 1 | 2006 | |
| HESS THOMAS P | Officer | VP Finance and CFO; VP Finance & CFO; VP, Finance & CFO | 5 | 2006–2008 | person page Fuzzy |
| MANNING MARTHA E | Officer | Sr VP, General Counsel & Sec; Sr. VP, General Counsel & Sec.; Sr.VP, General Counsel & Sec.; Sr.VP,General Counsel & Sec; SVP,General Counsel &Secretary | 5 | 2006–2008 | |
| GODDARD PAUL | Director | 11 | 2006–2011 | ||
| MADDEN DAVID | Director; Director,Officer; DirectorOther | Chairman, Interim Pres & CEO; Chairman, President & CEO | 15 | 2006–2011 | |
| ANIDO ARMANDO | Director | 9 | 2006–2011 | ||
| HAGER GEORGE V JR | Director | 9 | 2006–2011 | ||
| NASH CLAUDE | Director | 10 | 2006–2011 | ||
| NICKELSON DONALD E | Director | 12 | 2006–2011 | person page Fuzzy | |
| NELSEN ROBERT | Director | 2 | 2006–2007 | ||
| GEMAYEL GEORGES | Director | 9 | 2007–2011 | ||
| JACKSON DAVID | Officer | Sr. VP and CMO; Sr V.P & Chief Medical Officer; Sr.VP & Chief Medical Officer | 3 | 2007–2008 | |
| Salinas Eliseo Oreste | Officer | Sr. VP R&D and CMO; Sr. VP R&D & CMO; SVP R&D & CMO | 5 | 2008–2010 | |
| Magni Guido | Director | 7 | 2008–2011 | ||
| Webster Stephen W | Officer | Sr. V.P, Finance & CFO; SVP Finance & CFO; SVP, Finance & CFO | 7 | 2008–2011 | |
| Limongelli John M | Officer | Sr. VP,General Counsel & Sec.; Sr.VP, General Counsel & Sec; SVP, General Counsel & Secr; SVP, General Counsel & Secr.; SVP, General Counsel,Secretary; SVP,General Counsel &Secretary | 9 | 2008–2011 | |
| BIOTECHNOLOGY VALUE FUND II LP | Other; TenPercentOwnerOther | 12 | 2008–2009 | ||
| BIOTECHNOLOGY VALUE FUND L P | Other; TenPercentOwnerOther | 12 | 2008–2009 | ||
| BVF INC/IL | TenPercentOwner; TenPercentOwnerOther | 12 | 2008–2009 | ||
| BVF INVESTMENTS LLC | Other; TenPercentOwnerOther | 12 | 2008–2009 | ||
| BVF PARTNERS L P/IL | TenPercentOwner; TenPercentOwnerOther | 12 | 2008–2009 | ||
| Maurer George R | Officer | SVP Manuf & Pharma Technologie; SVP Manuf &PharmaTechnologies; SVP Manuf&Pharma Technologies; SVP Manuf & Pharm Technologies; SVP, Mfg. & Pharm Technologies | 8 | 2009–2011 | |
| LAMPERT MARK N | TenPercentOwner; TenPercentOwnerOther | 5 | 2009 | ||
| 14159 capital (GP), LLC | TenPercentOwner | 7 | 2010–2012 | ||
| Baker Biotech Capital (GP), LLC | TenPercentOwner | 3 | 2010–2012 | ||
| Baker Bros. Capital (GP), LLC | TenPercentOwner | 3 | 2010–2011 | ||
| Baker Brothers Life Sciences Capital (GP), LLC | TenPercentOwner | 8 | 2010–2012 | ||
| BAKER FELIX | TenPercentOwner | 24 | 2010–2012 | ||
| BAKER JULIAN | TenPercentOwner | 24 | 2010–2012 | ||
| Baker / Tisch Capital (GP), LLC | TenPercentOwner | 3 | 2010–2012 | ||
| CUBIST PHARMACEUTICALS INC | TenPercentOwner | 3 | 2011 | ||
| FRD Acquisition Corp | TenPercentOwner | 3 | 2011 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | ADOLOR CORP | SEC filers (EDGAR) | CIK (EXACT) | |
| Business registration | Adolor Corporation | State business registries | name and state | |
| Form 5500 plan sponsor | ADOLOR CORPORATION | EIN (EXACT) | ||
| Federal award recipient | ADOLOR CORPORATION | Federal spending (USAspending) | name and state | |
| Person page | Donald E Nickelson | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Thomas P Hess | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, PA first:
- COLLAGENEX PHARMACEUTICALS INC PA
- ORAPHARMA INC PA
- VICURON PHARMACEUTICALS INC PA
- INOVIO PHARMACEUTICALS, INC. PA
- PROTARGA INC PA
- Traws Pharma, Inc. PA
- MADRIGAL PHARMACEUTICALS, INC. PA
- Vitae Pharmaceuticals, Inc PA
- PhaseBio Pharmaceuticals Inc PA
- NeuBase Therapeutics, Inc. PA
In other datasets, the same topic (Health) in PA:
- Nonprofit: 445 FOUNDATION (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health